Discloses restructuring plan, Ruili Ke Mi resumes trading from March 3

LightningPacketLoss · 2026-03-06T03:00:31+00:00

Ruili Kemi plans to acquire a 16% stake in Wuhan Kedes through share issuance, with a transaction price of 16 million yuan. After completion, the company will achieve full control of the target. This transaction aims to enhance technological synergy and market application, consolidating the company's advantages in the automotive active safety system field.

LightningPacketLoss

2026-03-06 03:00:31

Abstract generation in progress

Beijing Business Daily (Reporter Ma Huanchang, Li Jiaxue) reported that on the evening of March 2, Ruili Kemi (001285) disclosed a restructuring draft, and the company’s stock will resume trading starting March 3.

The restructuring draft shows that Ruili Kemi plans to purchase a 16% stake in Wuhan Ruili Kedes Automotive Electronics Co., Ltd. (hereinafter referred to as “Wuhan Kedes”) through issuing shares. Before this transaction, Ruili Kemi already held an 84% stake in the target company and included it in the consolidated financial statements. After the transaction is completed, the company will have 100% control of the target company. The transaction price for the 16% stake in the target company is set at 16 million yuan. This transaction does not constitute a major asset reorganization but is considered an associated transaction.

It is understood that Wuhan Kedes mainly engages in the development and technical services of hardware and software for ABS, ESC, EPB, and other electronic control braking systems.

Ruili Kemi stated that this transaction will help the company deepen technological collaboration and expand market applications, further consolidating and strengthening its core competitiveness in the field of automotive active safety systems.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.